BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18400765)

  • 21. Endothelial dysfunction and inflammation after percutaneous coronary intervention.
    Blum A; Schneider DJ; Sobel BE; Dauerman HL
    Am J Cardiol; 2004 Dec; 94(11):1420-3. PubMed ID: 15566916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein incites atherosclerosis.
    Verma S
    Can J Cardiol; 2004 Aug; 20 Suppl B():29B-31B. PubMed ID: 15309202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart rate variability biofeedback as a behavioral neurocardiac intervention to enhance vagal heart rate control.
    Nolan RP; Kamath MV; Floras JS; Stanley J; Pang C; Picton P; Young QR
    Am Heart J; 2005 Jun; 149(6):1137. PubMed ID: 15976804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration of cardiac autonomic functions in patients with major depression: a study using heart rate variability measures.
    Udupa K; Sathyaprabha TN; Thirthalli J; Kishore KR; Lavekar GS; Raju TR; Gangadhar BN
    J Affect Disord; 2007 Jun; 100(1-3):137-41. PubMed ID: 17113650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies.
    Nicholson A; Kuper H; Hemingway H
    Eur Heart J; 2006 Dec; 27(23):2763-74. PubMed ID: 17082208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychological and clinical predictors of return to work after acute coronary syndrome.
    Bhattacharyya MR; Perkins-Porras L; Whitehead DL; Steptoe A
    Eur Heart J; 2007 Jan; 28(2):160-5. PubMed ID: 17185305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired endothelial function in coronary heart disease patients with depressive symptomatology.
    Sherwood A; Hinderliter AL; Watkins LL; Waugh RA; Blumenthal JA
    J Am Coll Cardiol; 2005 Aug; 46(4):656-9. PubMed ID: 16098431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease.
    Vlachopoulos C; Aznaouridis K; Ioakeimidis N; Rokkas K; Vasiliadou C; Alexopoulos N; Stefanadi E; Askitis A; Stefanadis C
    Eur Heart J; 2006 Nov; 27(22):2640-8. PubMed ID: 17056702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular disease. Does inflammation cut to the heart of the matter?
    Taubes G
    Science; 2002 Apr; 296(5566):242-5. PubMed ID: 11951014
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship between electrocardiographic and biochemical variables in coronary artery disease.
    Yue W; Schneider A; Rückerl R; Koenig W; Marder V; Wang S; Wichmann HE; Peters A; Zareba W
    Int J Cardiol; 2007 Jul; 119(2):185-91. PubMed ID: 17141341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depressive symptoms are related to decreased low-frequency heart rate variability in older adults with decompensated heart failure.
    Guinjoan SM; Castro MN; Vigo DE; Weidema H; Berbara C; Fahrer RD; Grancelli H; Nogués M; Leiguarda RC; Cardinali DP
    Neuropsychobiology; 2007; 55(3-4):219-24. PubMed ID: 17873496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension.
    Zoccali C
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S61-3. PubMed ID: 16565249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression and coronary artery disease.
    Frasure-Smith N; Lespérance F
    Herz; 2006 Dec; 31 Suppl 3():64-8. PubMed ID: 17575807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance, heart disease and inflammation. Identifying the 'at-risk' patient: the earlier the better? The role of inflammatory markers.
    Koenig W
    Int J Clin Pract Suppl; 2002 Oct; (132):23-30. PubMed ID: 12425360
    [No Abstract]   [Full Text] [Related]  

  • 35. [Platelet activation and inflammation markers in patients with coronary heart disease and depression].
    Buriachkovskaia LI; Poliakova EO; Zorin AV; Uchitel' IA; Dovlatova NL; Masenko VP; Sumarokov AB; Kadushina EB; Kuzentsova TA; Pogorelova TE; Chazov EI
    Ter Arkh; 2006; 78(10):9-14. PubMed ID: 17180929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cognitive performance in patients with coronary heart disease and cardiovascular risk factors in Chile].
    Delgado-Derio C; Vasquez-Vivar C; Orellana-Pineda P; Reccius-Meza A; Donoso-Sepúlveda A; Behrens-Pellegrino MI
    Rev Neurol; 2008 Jan 1-15; 46(1):24-9. PubMed ID: 18214823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introduction to risk assessment and serum risk markers for the prevention of coronary heart disease and other potential conditions that impact men's health, part II: what do I tell my patients?
    Moyad MA
    Urol Clin North Am; 2004 May; 31(2):199-205. PubMed ID: 15123399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial function: ready for prime time?
    Verma S; Szmitko PE; Anderson TJ
    Can J Cardiol; 2004 Nov; 20(13):1335-9. PubMed ID: 15565197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of depression on the prognosis of cardiovascular diseases].
    Bounhoure JP; Galinier M; Curnier D; Bousquet M; Bes A
    Bull Acad Natl Med; 2006 Nov; 190(8):1723-31; discussion 1731-2. PubMed ID: 17650755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of depression in patients with coronary heart disease.
    Vieweg WV; Julius DA; Fernandez A; Wulsin LR; Mohanty PK; Beatty-Brooks M; Hasnain M; Pandurangi AK
    Am J Med; 2006 Jul; 119(7):567-73. PubMed ID: 16828625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.